Cardiovascular manifestations seen in obstructive sleep apnea.

Cardiovascular manifestations seen in obstructive sleep apnea. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Cardiovascular manifestations seen in obstructive sleep apnea. Abstract Text:

Wilbert S Aronow,Wilbert S Aronow,Wilbert S Aronow,

Patients with obstructive sleep apnea (OSA) have an increased prevalence of systemic and pulmonary hypertension, left ventricular (LV) hypertrophy, LV systolic and diastolic dysfunction, and congestive heart failure, increased platelet aggregability, and increased susceptibility to thrombotic and embolic cardiac and cerebrovascular events. Patients with OSA have an increased prevalence of coronary artery disease, myocardial infarction, nocturnal angina, and myocardial ischemia, arrhythmias, and sudden cardiac death. Patients with OSA also have an increased prevalence of stroke. Treatment of OSA with continuous positive airway pressure improves cardiac efficiency in patients with heart failure, causes a reduction in the frequency of nocturnal ischemic ST-segment depression, relieves nocturnal angina, and causes a reduction in the occurrence of new cardiovascular events and an increase in the time to such events.

Cardiovascular manifestations seen in obstructive sleep apnea. Publishing Authors By Initials

WS Aronow,WS Aronow,WS Aronow,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Cardiovascular manifestations seen in obstructive sleep apnea. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Comprehensive therapy

VOLUME: 33

Page Numbers: 82-6

Journal Abbreviation:

ISSN: 0098-8243

DAY: 16

MONTH: 11

YEAR: 2007

Cardiovascular manifestations seen in obstructive sleep apnea. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7605837

Cardiovascular manifestations seen in obstructive sleep apnea. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Cardiovascular manifestations seen in obstructive sleep apnea. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Cardiovascular manifestations seen in obstructive sleep apnea.

AFFILIATION: Department of Medicine, Divisions of Cardiology, Pulmonary/Critical Care, and Geriatrics, New York Medical College, Valhalla, NY, 10595, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Compr Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Cardiovascular manifestations seen in obstructive sleep apnea Related Publications

• A propensity-matched study of the association of physical function and outcomes in geriatric heart failure.
• Aortic stenosis.
• Atherosclerotic vascular disease may be associated with osteoporosis or osteopenia in postmenopausal women: a preliminary study.
• Cardiovascular manifestations seen in obstructive sleep apnea.
• Clinical implications of left ventricular function in patients with acute myocardial infarction.
• Effect of beta blockers on mortality and morbidity in persons treated for congestive heart failure.
• Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome.
• GenomeTrafac: a whole genome resource for the detection of transcription factor binding site clusters associated with conventional and microRNA encoding genes conserved between mouse and human gene orthologs.
• Heart failure-complicating acute myocardial infarction.
• Left ventricular filling pressures in cardiac patients.
• Management of chronic obstructive pulmonary disease.
• Management of hyperlipidemia with statins in the older patient.
• Management of peripheral arterial disease of the lower extremities.
• Optimal medical therapy after MI in the elderly.
• Peripheral arterial disease in the elderly.
• PolyDoms: a whole genome database for the identification of non-synonymous coding SNPs with the potential to impact disease.
• Prevalence of a hemoglobin A1c less than 7.0%, of a blood pressure less than 130/80 mm Hg, and of a serum low-density lipoprotein cholesterol less than 100 mg/dL in older patients with diabetes mellitus in an academic nursing home.
• Prevalence of adequate and of optimal control of serum low-density lipoprotein cholesterol in an academic nursing home.
• Prevalence of use of antiplatelet drugs, Beta blockers, statins, and Angiotensin-converting enzyme inhibitors or Angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home.
• Quality of care of nursing home residents hospitalized with heart failure.
• Recognition and management of aortic stenosis in the elderly.
• Reply to letter to the editor: treatment of hyperlipidemia in the nursing home.
• Tracer studies of ingestion of dust by urban children.
• Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer.
• Treatment after myocardial infarction.
• Treatment of heart failure with abnormal left ventricular systolic function in the elderly.
• Treatment of heart failure with decreased left ventricular ejection fraction.
• Treatment of heart failure with normal left ventricular ejection fraction.
• Treatment of postmenopausal osteoporosis.
• Winner of the Theodore E. Woodward Award: c-Myb and the coordinate regulation of thymic genes.